Selective cyclooxygenase inhibition improves hepatic encephalopathy in fulminant hepatic failure of rat

European Journal of Pharmacology

Volumn 666, Issue 1-3, 2011, Pages 226-232

  Chang, Ching Chih ^a,c   Wang, Sun Sang ^a,c   Huang, Hui Chun ^a,c   Chan, Cho Yu ^b,c   Lee, Fa Yauh ^a,c   Lin, Han Chieh ^a,c   Nong, Jing Yi ^a   Chuang, Chiao Lin ^a,c   Lee, Shou Dong ^a,c  

^a TAIPEI VETERANS GENERAL HOSPITAL   (Taiwan)

^b CHINA MEDICAL UNIVERSITY HOSPITAL   (Taiwan)

^c NATIONAL YANG MING UNIVERSITY   (Taiwan)

Author keywords

Fulminant hepatic failure; Hepatic encephalopathy; Selective cyclooxygenase inhibition

Indexed keywords

5 (4 CHLOROPHENYL) 1 (4 METHOXYPHENYL) 3 TRIFLUOROMETHYL 1H PYRAZOLE; 6 OXOPROSTAGLANDIN F1 ALPHA; ALANINE AMINOTRANSFERASE; AMMONIA; ASPARTATE AMINOTRANSFERASE; BILIRUBIN; CYCLOOXYGENASE 1; CYCLOOXYGENASE 2; INDUCIBLE NITRIC OXIDE SYNTHASE; MESSENGER RNA; N (2 CYCLOHEXYLOXY 4 NITROPHENYL)METHANESULFONAMIDE; TUMOR NECROSIS FACTOR ALPHA;

AMMONIA BLOOD LEVEL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DISEASE SEVERITY; DRUG EFFECT; ENZYME INHIBITION; FULMINANT HEPATIC FAILURE; HEPATIC ENCEPHALOPATHY; HISTOPATHOLOGY; MALE; MORTALITY; MOTOR ACTIVITY; NONHUMAN; PRIORITY JOURNAL; PROSTAGLANDIN BLOOD LEVEL; RAT;

AMMONIA; ANIMALS; CYCLOOXYGENASE 1; CYCLOOXYGENASE 2; CYCLOOXYGENASE INHIBITORS; GENE EXPRESSION REGULATION, ENZYMOLOGIC; HEPATIC ENCEPHALOPATHY; LIVER; LIVER FAILURE, ACUTE; MALE; MOTOR ACTIVITY; NITRIC OXIDE SYNTHASE TYPE II; PROSTAGLANDINS F; RATS; RATS, SPRAGUE-DAWLEY; RNA, MESSENGER; SURVIVAL ANALYSIS; THIOACETAMIDE; TUMOR NECROSIS FACTOR-ALPHA;

EID: 79959966014     PISSN: 00142999     EISSN: 18790712     Source Type: Journal    
DOI: 10.1016/j.ejphar.2011.04.060     Document Type: Article

References (43)

1. S. Aggarwal, D. Kramer, H. Yonas, W. Obrist, Y. Kang, M. Martin, and R. Policare Cerebral hemodynamic and changes in fulminant hepatic failure: a retrospective study Hepatology 19 1994 80 87 (Pubitemid 24020475)
2. S. Ahboucha, W. Jiang, N. Chatauret, O. Mamer, G.B. Baker, and R.F. Butterworth Indomethacin improves locomotor deficit and reduces brain concentrations of neuroinhibitory steroids in rats following portacaval anastomosis Neurogastroenterol. Motil. 20 2008 949 957 (Pubitemid 352019719)
3. H. Araki, and A.M. Lefer Cytoprotective actions of prostacyclin during hypoxia in the isolated perfused cat liver Am. J. Physiol. 238 1980 H176 H181
4. S.J. Armstrong, Y. Xu, and S.T. Davidge Effects of chronic PGHS-2 inhibition on PGHS-dependent vasoconstriction in the aged female rat Cardiovasc. Res. 61 2004 333 338 (Pubitemid 38091773)
5. C. Bolego, C. Buccellati, A. Prada, R.M. Gaion, G. Folco, and A. Sala Critical role of COX-1 in prostacyclin production by human endothelial cells under modification of hydroperoxide tone FASEB J. 23 2009 605 612
6. J. Bruix, J. Bosch, D. Kravetz, R. Mastai, and J. Rodez Effects of prostacyclin inhibition on systemic and hepatic hemodynamics in patients with cirrhosis of the liver Gastroenterology 88 1985 430 435 (Pubitemid 15194706)
7. R.F. Butterworth, M.D. Norenberg, V. Felipo, P. Ferenci, J. Albrecht, and A.T. Blei Members of the ISHEN Commission on Experimental Models of HE. Experimental models of hepatic encephalopathy: ISHEN guidelines Liver Int. 29 2009 783 788
8. I.L. Bykov, M. Palmen, K.D. Rainsford, and K.O. Lindros Chronic effects of celecoxib, a cyclooxygenase-2 inhibitor, cause enhanced alcohol-induced liver steatosis in rats Inflammopharmacology 14 2006 36 41
9. O. Cauli, R. Rodrigo, B. Piedrafita, J. Boix, and V. Felipo Inflammation and hepatic encephalopathy: ibuprofen restores learning ability in rats with portacaval shunts Hepatology 46 2007 514 519 (Pubitemid 47344787)
10. O. Cauli, R. Rodrigo, B. Piedrafita, M. Llansola, M.T. Mansouri, and V. Felipo Neuroinflammation contributes to hypokinesia in rats with hepatic encephalopathy: ibuprofen restores its motor activity J. Neurosci. Res. 87 2009 1369 1374
11. C.Y. Chan, S.W. Huang, T.F. Wang, R.H. Lu, F.Y. Lee, F.Y. Chang, C.J. Chu, Y.C. Chen, C.C. Chan, H.C. Huang, and S.D. Lee Lack of detrimental effects of nitric oxide inhibition in bile duct-ligated rats with hepatic encephalopathy Eur. J. Clin. Invest. 34 2004 122 128
12. C.Y. Chan, F.Y. Lee, T.F. Wang, S.W. Huang, F.Y. Chang, R.H. Lu, Y.C. Chen, S.S. Wang, H.C. Huang, and S.D. Lee Lack of detrimental or therapeutic effects of cyclooxygenase inhibition in bile duct-ligated rats with hepatic encephalopathy J. Gastroenterol. Hepatol. 21 2006 1483 1487
13. S.H. Choi, R. Langenbach, and F. Bosetti Genetic deletion or pharmacological inhibition of cyclooxygenase-1 attenuate lipopolysaccharide- induced inflammatory response and brain injury FASEB J. 22 2008 1491 1501 (Pubitemid 351656789)
14. C.J. Chu, S.S. Wang, F.Y. Lee, F.Y. Change, M.C. Lin, M.C. Hou, C.C. Chan, S.L. Wu, C.T. Chen, H.C. Huang, and S.D. Lee Detrimental effects of nitric oxide inhibition on hepatic encephalopathy in rats with thioacetamide-induced fulminant hepatic failure Eur. J. Clin. Invest. 31 2001 156 163
15. C.J. Chu, C.C. Hsiao, T.F. Wang, C.Y. Chan, F.Y. Lee, F.Y. Chang, Y.C. Chen, H.C. Huang, S.S. Wang, and S.D. Lee Prostacyclin inhibition by indomethacin aggravates hepatic damage and encephalopathy in rats with thioacetamide-induced fulminant hepatic failure World J. Gastroenterol. 11 2005 232 236
16. C. Chung, J. Gottstein, and A.T. Blei Indomethacin prevents the development of experimental ammonia-induced brain edema in rats after portacaval anastomosis Hepatology 34 2001 249 254 (Pubitemid 32702336)
17. H.S. Conjeevaram, A. Nagle, A. Katz, K. Kaminsky-Russ, A.J. McCullough, and K.D. Mullen Reversal of behavior changes in rats subjected to portacaval shunt with oral neomycin therapy Hepatology 19 1994 1245 1250 (Pubitemid 24134248)
18. A. Fernández-Martínez, N.A. Callejas, M. Casado, L. Boscá, and P. Martín-Sanz Thioacetamide-induced liver regeneration involves the expression of cyclooxygenase 2 and nitric oxide synthase 2 in hepatocytes J. Hepatol. 40 2004 963 970 (Pubitemid 38670130)
19. S.H. Gammal, and E.A. Hones Hepatic encephalopathy Med. Clin. North Am. 73 1989 793 813 (Pubitemid 19163725)
20. M. Graupera, S. March, P. Engel, J. Rodés, J. Bosch, and J.C. García-Pagán Sinusoidal endothelial COX-1-derived prostanoids modulate the hepatic vascular tone of cirrhotic rat livers Am. J. Physiol. Gastrointest. Liver Physiol. 288 2005 G763 G770
21. R.J. Groszmann Hyperdynamic circulation of liver disease 40 years later: pathophysiology and clinical consequences Hepatology 20 1994 1359 1363 (Pubitemid 24323589)
22. B. Gu, P. Desjardins, and R.F. Butterworth Selective increase of neuronal cyclooxygenase-2 (COX-2) expression in vulnerable brain regions of rats with experimental Wernicke's encephalopathy: effect of nimesulide Metab. Brain Dis. 23 2008 175 187
23. F. Guarner, N.K. Boughton-Smith, G.J. Blackwell, and S. Moncada Reduction by prostacyclin of acetaminophen-induced liver toxicity in the mouse Hepatology 8 1988 248 253
24. H.C. Huang, S.S. Wang, F.Y. Lee, C.Y. Chan, F.Y. Chang, H.C. Lin, C.J. Chu, Y.C. Chen, and S.D. Lee Simvastatin for rats with thioacetamide-induced liver failure and encephalopathy J. Gastroenterol. Hepatol. 23 2008 e236 e242
25. A.L. Hunter, M.A. Holscher, and R.A. Neal Thioacetamide-induced hepatic necrosis: involvement of the mixed-function oxidase enzyme system J. Pharmacol. Exp. Ther. 200 1977 439 448 (Pubitemid 8037503)
26. D.J. Jaworowicz Jr.; P.J. Korytko, S. Singh Lakhman, and K.M. Boje Nitric oxide and prostaglandin E2 formation parallels blood-brain barrier disruption in an experimental rat model of bacterial meningitis Brain Res. Bull. 46 1998 541 546 (Pubitemid 28409184)
27. W. Jiang, P. Desjardins, and R.F. Butterworth Minocycline attenuates oxidative/nitrosative stress and cerebral complications of acute liver failure in rats Neurochem. Int. 55 2009 601 605
28. W. Jiang, P. Desjardins, and R.F. Butterworth Direct evidence for central proinflammatory mechanisms in rats with experimental acute liver failure: protective effect of hypothermia J. Cereb. Blood Flow Metab. 29 2009 944 952
29. F.S. Larsen, G.M. Knudsen, O.B. Paulson, and H. Vilstrup Cerebral blood flow autoregulation is absent in rats with fulminant hepatic failure J. Hepatol. 21 1994 491 495 (Pubitemid 24324020)
30. F.S. Larsen, E. Ejlersen, B.A. Hansen, G.M. Knudsen, N. Tygstrup, and N.H. Secher Functional loss of cerebral blood flow autoregulation in patients with fulminant hepatic failure J. Hepatol. 46 1995 212 217
31. ω-nitro-l-arginine administration corrects peripheral vasodilatation and systemic capillary hypotension and ameliorates plasma volume expansion and sodium retention in portal hypertensive rats Hepatology 17 1993 84 90 (Pubitemid 23027389)
32. H. Liu, W. Wei, and X. Li Celecoxib exacerbates hepatic fibrosis and induces hepatocellular necrosis in rats treated with porcine serum Prostaglandins Other Lipid Mediat. 88 2009 63 67
33. A.H. Lockwood, E.W.H. Yap, and W. Wong Cerebral ammonia metabolism in patients with severe liver disease and minimal hepatic encephalopathy J. Cereb. Blood Flow Metab. 11 1991 337 341
34. N. Masaki, Y. Ohta, H. Shirataki, I. Ogata, S. Hayashi, S. Yamada, K. Hirata, S. Nagoshi, S. Mochida, and T. Tomiya Hepatocyte membrane stabilization by prostaglandins E1 and E2: favorable effects on rat liver injury Gastroenterology 102 1992 572 576
35. Y. Mizoguchi, H. Tsutsui, K. Miyajima, Y. Sakagami, S. Seki, K. Kobayashi, S. Yamamoto, and S. Morisawa The protective effects of prostaglandin E1 in an experimental massive hepatic cell necrosis model Hepatology 7 1987 1184 1188 (Pubitemid 18014188)
36. D.D. Mousseau, and R.F. Butterworth Current theories on the pathogenesis of hepatic encephalopathy Soc. Exp. Biol. Med. 206 1994 329 344 (Pubitemid 24270091)
37. A. Narasimha, J. Watanabe, J.A. Lin, S. Hama, R. Langenbach, M. Navab, A.M. Fogelman, and S.T. Reddy A novel anti-atherogenic role for COX-2-potential mechanism for the cardiovascular side effects of COX-2 inhibitors Prostaglandins Other Lipid Mediat. 84 2007 24 33 (Pubitemid 47069931)
38. Y.H. Paik, J.K. Kim, J.I. Lee, S.H. Kang, D.Y. Kim, S.H. An, S.J. Lee, D.K. Lee, K.H. Han, C.Y. Chon, S.I. Lee, K.S. Lee, and D.A. Brenner Celecoxib induces hepatic stellate cell apoptosis through inhibition of Akt activation and suppresses hepatic fibrosis in rats Gut 58 2009 1517 1527
39. S. Sherlock Fulminant hepatic failure Adv. Intern. Med. 38 1993 245 267
40. N.J. Skill, N.G. Theodorakis, Y.N. Wang, J.M. Wu, E.M. Redmond, and J.V. Sitzmann Role of cyclooxygenase isoforms in prostacyclin biosynthesis and murine prehepatic portal hypertension Am. J. Physiol. Gastrointest. Liver Physiol. 295 2008 G953 G964
41. C.J. Smith, Y. Zhang, C.M. Koboldt, J. Muhammad, B.S. Zweifel, A. Shaffer, J.J. Talley, J.L. Masferrer, K. Seibert, and P.C. Isakson Pharmacological analysis of cyclooxygenase-1 in inflammation Proc. Natl. Acad. Sci. U. S. A. 95 1998 13313 13318 (Pubitemid 28509568)
42. F.E. Xavier, J. Blanco-Rivero, E. Sastre, L. Badimón, and G. Balfagón Simultaneous inhibition of TXA(2) and PGI(2) synthesis increases NO release in mesenteric resistance arteries from cirrhotic rats Clin. Sci. (Lond) 119 2010 283 292
43. J. Yu, E. Ip, A. Dela Peña, J.Y. Hou, J. Sesha, N. Pera, P. Hall, R. Kirsch, I. Leclercq, and G.C. Farrell COX-2 induction in mice with experimental nutritional steatohepatitis: role as pro-inflammatory mediator Hepatology 43 2006 826 836